Teladoc Health, Inc. (TDOC) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist GOREVIC JASON N mit 197,728 Aktien. Weitere bedeutende Anteilseigner sind Vandervoort Adam C und Kornwasser Laizer.
In den letzten 12 Monaten haben Insider 78 Transaktionen in TDOC Aktien getätigt — 24 Käufe (im Wert von $69.4K) und 27 Verkäufe (im Wert von $1.63M). Insider-Verkäufe haben die Käufe in diesem Zeitraum übertroffen.
TDOC Insider-Beteiligungen
Größter Aktionär
GOREVIC JASON N
197,728 Aktien
Käufe (12 Monate)
24
$69.4K Wert
Verkäufe (12 Monate)
27
$1.63M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Gorevic Jason N |
Chief Executive Officer |
197,728 |
2024-03-20 |
|
| 2 |
Vandervoort Adam C |
Chief Legal Officer, Secretary |
181,661 |
2026-03-03 |
|
| 3 |
Kornwasser Laizer |
Advisor To the CEO |
100,994 |
2024-08-05 |
|
| 4 |
Smith Michael S |
Director |
53,648 |
2026-02-19 |
|
| 5 |
Salka Susan R |
Director |
48,638 |
2026-04-01 |
|
| 6 |
Napolitano Richard J |
Chief Accounting Officer |
37,500 |
2024-03-20 |
|
| 7 |
Daniel Karen L |
Director |
36,995 |
2024-05-24 |
|
| 8 |
Raman-tangella Vidya |
Chief Medical Officer |
33,665 |
2024-09-05 |
|
| 9 |
Fenwick Sandra L |
Director |
28,986 |
2025-05-23 |
|
| 10 |
Shedlarz David L |
Director |
28,986 |
2025-05-23 |
|
| 11 |
Mckinley Thomas |
Director |
28,986 |
2025-05-23 |
|
| 12 |
Jacobson Catherine |
Director |
28,986 |
2025-05-23 |
|
| 13 |
Smith Mark Douglas |
Director |
28,986 |
2025-05-23 |
|
| 14 |
Snow David B Jr |
Director |
28,986 |
2025-05-23 |
|
| 15 |
Turitz Andrew |
EVP, Corporate Development |
20,773 |
2024-09-05 |
|
| 16 |
Divita Charles Iii |
Chief Executive Officer |
18,210 |
2026-03-12 |
|
| 17 |
Waters Michael Willem |
Chief Operating Officer |
12,679 |
2024-09-04 |
|
| 18 |
Jensen Claus Torp |
Chief Innovation Officer |
12,264 |
2023-12-05 |
|
| 19 |
Catapano Joseph Ronald |
Chief Accounting Officer |
10,924 |
2026-04-03 |
|
| 20 |
Bliss Kelly |
President, U.s. Group Health |
10,398 |
2026-03-12 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-04-02 |
Catapano Joseph Ronald |
Chief Accounting Officer |
Informierter Verkauf |
675 |
$5.11 |
$3.45K |
| 2026-04-01 |
Catapano Joseph Ronald |
Chief Accounting Officer |
Optionsausübung |
2,083 |
- |
- |
| 2026-03-30 |
Salka Susan R |
Director |
RSU-Zuteilung |
48,638 |
- |
- |
| 2026-03-30 |
Salka Susan R |
Director |
Unbekannt |
- |
- |
- |
| 2026-02-27 |
Bliss Kelly |
President, U.s. Group Health |
Optionsausübung (Verkauf) |
5,198 |
- |
- |
| 2026-03-11 |
Divita Charles Iii |
Chief Executive Officer |
Informierter Verkauf |
27,731 |
$5.49 |
$152.24K |
| 2026-03-10 |
Divita Charles Iii |
Chief Executive Officer |
Optionsausübung (Verkauf) |
25,493 |
- |
- |
| 2026-03-02 |
Bliss Kelly |
President, U.s. Group Health |
Informierter Verkauf |
26,647 |
$5.12 |
$136.35K |
| 2026-03-01 |
Bliss Kelly |
President, U.s. Group Health |
RSU-Zuteilung |
181,661 |
- |
- |
| 2026-02-27 |
Bliss Kelly |
President, U.s. Group Health |
Optionsausübung (Verkauf) |
1,186 |
- |
- |
| 2026-03-02 |
Catapano Joseph Ronald |
Chief Accounting Officer |
Informierter Verkauf |
1,333 |
$5.12 |
$6.82K |
| 2026-03-01 |
Catapano Joseph Ronald |
Chief Accounting Officer |
RSU-Zuteilung |
15,000 |
- |
- |
| 2026-02-27 |
Catapano Joseph Ronald |
Chief Accounting Officer |
Optionsausübung (Verkauf) |
155 |
- |
- |
| 2026-03-02 |
Vandervoort Adam C |
Chief Legal Officer, Secretary |
Informierter Verkauf |
27,083 |
$5.12 |
$138.58K |
| 2026-03-01 |
Vandervoort Adam C |
Chief Legal Officer, Secretary |
RSU-Zuteilung |
181,661 |
- |
- |
| 2026-02-27 |
Vandervoort Adam C |
Chief Legal Officer, Secretary |
Optionsausübung (Verkauf) |
1,510 |
- |
- |
| 2026-03-02 |
Divita Charles Iii |
Chief Executive Officer |
Informierter Verkauf |
50,145 |
$5.12 |
$256.59K |
| 2026-03-01 |
Divita Charles Iii |
Chief Executive Officer |
RSU-Zuteilung |
692,041 |
- |
- |
| 2026-02-27 |
Divita Charles Iii |
Chief Executive Officer |
Optionsausübung (Verkauf) |
7,864 |
- |
- |
| 2022-02-27 |
Divita Charles Iii |
Chief Executive Officer |
Optionsausübung |
169,107 |
- |
- |
| 2026-02-18 |
Smith Michael S |
Director |
RSU-Zuteilung |
53,648 |
- |
- |
| 2026-02-18 |
Smith Michael S |
Director |
Unbekannt |
- |
- |
- |
| 2026-01-05 |
Catapano Joseph Ronald |
Chief Accounting Officer |
Informierter Verkauf |
758 |
$7.15 |
$5.42K |
| 2026-01-02 |
Catapano Joseph Ronald |
Chief Accounting Officer |
Optionsausübung |
2,083 |
- |
- |
| 2025-12-19 |
Evans Jason Eric |
Director |
Optionsausübung (Verkauf) |
1,016 |
- |
- |
